Human procarboxypeptidase B: Three-dimensional structure and implications for thrombin-activatable fibrinolysis inhibitor (TAFI)

Journal of Molecular Biology

Volumn 321, Issue 3, 2002, Pages 537-547

  Barbosa Pereira, Pedro José ^a   Segura Martín, Sonia ^b   Oliva, Baldomero ^c   Ferrer Orta, Cristina ^a   Avilés, Francesc X ^b   Coll, Miquel ^a   Gomis Rüth, F Xavier ^a   Vendrell, Josep ^b  

^a INSTITUT DE BIOLOGIA MOLECULAR DE BARCELONA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Procarboxypeptidase B; TAFI; Three dimensional model; Three dimensional structure

Indexed keywords

CARBOXYPEPTIDASE B; ENZYME PRECURSOR; EXOPEPTIDASE; GLOBULAR PROTEIN; HYDROLASE; PLASMINOGEN; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; DRUG STRUCTURE; ENZYME ACTIVE SITE; ENZYME BINDING; ENZYME CONFORMATION; ENZYME STRUCTURE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; STRUCTURE ANALYSIS; X RAY DIFFRACTION;

EID: 0036384505     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(02)00648-4     Document Type: Article

References (49)

1. Vendrell, J., Cuchillo, C. M. & Aviles, F. X. (1990). The tryptic activation pathway of monomeric procarboxypeptidase A. J. Biol. Chem. 265, 6949-6953.
2. Folk, J. E., Piez, K. A., Carroll, W. R. & Gladner, J. A. (1960). Carboxypeptidase B. IV. Purification and characterization of the porcine enzyme. J. Biol. Chem. 235, 2272-2277.
3. Rawlings, N. D., O'Brien, E. & Barrett, A. J. (2002). MEROPS: the protease database. Nucl. Acids Res. 30, 343-346.
4. Gomis-Rüth, F. X., Companys, V., Qian, Y., Fricker, L. D., Vendrell, J., Avilés, F. X. & Coll, M. (1999). Crystal structure of avian carboxypeptidase D domain II: a prototype for the regulatory metallo-carboxypeptidase subfamily. EMBO J. 18, 5817-5826.
5. Tan, F., Rehli, M., Krause, S. W. & Skidgel, R. A. (1997). Sequence of human carboxypeptidase D reveals it to be a member of the regulatory carboxypeptidase family with three tandem active site domains. Biochem. J. 327, 81-87.
6. Kuroki, K., Eng, F., Ishikawa, T., Turck, C., Harada, F. & Ganem, D. (1995). gp180, a host cell glycoprotein that binds duck hepatitis B virus particles, is encoded by a member of the carboxypeptidase gene family. J. Biol. Chem. 270, 15022-15028.
7. Eaton, D. L., Malloy, B. E., Tsai, S. P., Henzel, W. & Drayna, D. (1991). Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma. J. Biol. Chem. 266, 21833-21838.
8. Bajzar, L., Manuel, R. & Nesheim, M. E. (1995). Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J. Biol. Chem. 270, 14477-14484.
9. Boffa, M. B., Reid, T. S., Joo, E., Nesheim, M. E. & Koschinsky, M. L. (1999). Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B). Biochemistry, 38, 6547-6558.
10. Nesheim, M. E. (1999). TAFI. Fibrinol. Proteol. 13, 72-77.
11. Wang, W., Hendriks, D. F. & Scharpe, S. S. (1994). Carboxypeptidase U a plasma carboxypeptidase with high affinity for plasminogen. J. Biol. Chem. 269, 15937-15944.
12. Bouma, B. N., Marx, P. F., Mosnier, L. O. & Meijers, J. C. (2001). Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U). Thromb. Res. 101, 329-354.
13. Amiral, J. & Vissac, A. M. (2001). A new two-site ELISA for measuring thrombin activable fibrinolysis inhibitor (TAFI), or its activated form (TAFIa). In BMC Meeting Abstracts: 2nd Hot Topic Workshop on CRP, vol. 1, p. 39.
14. van Tilburg, N. H., Rosendaal, F. R. & Bertina, R. M. (2000). Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis. Blood, 95, 2855-2859.
15. Franco, R. F., Fagundes, M. G., Meijers, J. C., Reitsma, P. H., Lourenco, D., Morelli, V. et al. (2001). Identification of polymorphisms in the 5′-untranslated region of the tafi gene: relationship with plasma TAFI levels and risk of venous thrombosis. Haematologica, 86, 510-517.
16. Silveira, A., Schatteman, K., Goossens, F., Moor, E., Scharpe, S., Stromqvist, M. et al. (2000). Plasma procarboxypeptidase U in men with symptomatic coronary artery disease. Thromb. Haemost. 84, 364-368.
17. Van Thiel, D. H., George, M. & Fareed, J. (2001). Low levels of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with chronic liver disease. Thromb. Haemost. 85, 667-670.
18. Boffa, M. B., Wang, W., Bajzar, L. & Nesheim, M. E. (1998). Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties. J. Biol. Chem. 273, 2127-2135.
19. Boffa, M. B., Bell, R., Stevens, W. K. & Nesheim, M. E. (2000). Roles of thermal instability and proteolytic cleavage in regulation of activated thrombin-activable fibrinolysis inhibitor. J. Biol. Chem. 275, 12868-12878.
20. Marx, P. F., Hackeng, T. M., Dawson, P. E., Griffin, J. H., Meijers, J. C. & Bouma, B. N. (2000). Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage. J. Biol. Chem. 275, 12410-12415.
21. Villegas, V., Vendrell, J. & Aviles, X. (1995). The activation pathway of procarboxypeptidase B from porcine pancreas: participation of the active enzyme in the proteolytic processing. Protein Sci. 4, 1792-1800.
22. Coll, M., Guasch, A., Aviles, F. X. & Huber, R. (1991). Three-dimensional structure of porcine procarboxypeptidase B: a structural basis of its inactivity. EMBO J. 10, 1-9.
23. Schechter, I. & Berger, A. (1967). On the size of active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27, 157-162.
24. Rees, D. C. & Lipscomb, W. N. (1982). Refined crystal structure of the potato inhibitor complex of carboxypeptidase A at 2.5 Å resolution. J. Mol. Biol. 160, 475-498.
25. García-Sáez, I., Reverter, D., Vendrell, J., Avilés, F. X. & Coll, M. (1997). The three-dimensional structure of human procarboxypeptidase A2. Deciphering the basis of the inhibition, activation and intrinsic activity of the zymogen. EMBO J. 16, 6906-6913.
26. Guasch, A., Coll, M., Avilés, F. X. & Huber, R. (1992). Three-dimensional structure of porcine pancreatic procarboxypeptidase A. A comparison of the A and B zymogens and their determinants for inhibition and activation. J. Mol. Biol. 224, 141-157.
27. Gomis-Rüth, F. X., Gómez, M., Bode, W., Huber, R. & Avilés, F. X. (1995). The three-dimensional structure of the native ternary complex of bovine pancreatic procarboxypeptidase A with proproteinase E and chymotrypsinogen C. EMBO J. 14, 4387-4394.
28. Rees, D. C., Lewis, M. & Lipscomb, W. N. (1983). Refined crystal structure of carboxypeptidase A at 1.54 Å resolution. J. Mol. Biol. 168, 367-387.
29. Clauser, E., Gardell, S. J., Craik, C. S., MacDonald, R. J. & Rutter, W. J. (1988). Structural characterization of the rat carboxypeptidase A1 and B genes. Comparative analysis of the rat carboxypeptidase gene family. J. Biol. Chem. 263, 17837-17845.
30. Sippl, M. J. (1993). Recognition of errors in three-dimensional structures of proteins. Proteins, 17, 355-362.
31. Muñoz, V. & Serrano, L. (1997). Development of the multiple sequence approximation within the AGADIR model of alpha-helix formation: comparison with Zimm-Bragg and Lifson-Roig formalisms. Biopolymers, 41, 495-509.
32. Ventura, S., Villegas, V., Sterner, J., Larson, J., Vendrell, J., Hershberger, C. L. & Avilés, F. X. (1999). Mapping the pro-region of carboxypeptidase B by protein engineering. Cloning, overexpression, and mutagenesis of the porcine proenzyme. J. Biol. Chem. 28, 19925-19933.
33. Otwinowski, Z. & Minor, W. (1993). DENZO: A Film Processing for Macromolecular Crystallography, Yale University, New Haven.
34. Collaborative Computational Project, No 4 (1994). The CCP4 suite: programs for protein crystallography. Acta Crystallog. sect. D, 50, 760-763.
35. Navaza, J. (1994). AMoRe: an automated package for molecular replacement. Acta Crystallog. sect. A, 50, 157-163.
36. Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W. et al. (1998). Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallog. sect. D, 54, 905-921.
37. Roussel, A. & Cambilleau, C. (1989). Turbo-Frodo. Silicon Graphics Geometry Partners Directory, pp. 77-79, Silicon Graphics, Mountain View, CA.
38. Sheldrick, G. M. & Schneider, T. R. (1997). SHELXL: high resolution refinement. In Methods in Enzymology (Carter, C. W. & Sweet, R. M., eds), vol. 277, pp. 319-343, Academic Press, San Diego, CA.
39. Thompson, J. D., Higgins, D. G. & Gibson, T. J. (1994). CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix.choice. Nucl. Acids Res. 22, 4673-4680.
40. Rost, B., Sander, C. & Schneider, R. (1994). PHD - an automatic mail server for protein secondary structure prediction. Comput. Appl. Biosci. 10, 53-60.
41. Kabsch, W. & Sander, C. (1983). Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers, 22, 2577-2637.
42. Orengo, C. A., Brown, N. P. & Taylor, W. R. (1992). Fast structure alignment for protein databank searching. Proteins: Struct. Funct. Genet. 14, 139-167.
43. Eddy, S. R. (1998). Profile hidden Markov models. Bioinformatics, 14, 755-763.
44. Sali, A. & Blundell, T. L. (1993). Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779-815.
45. Oliva, B., Bates, P. A., Querol, E., Aviles, F. X. & Sternberg, M. J. (1997). An automated classification of the structure of protein loops. J. Mol. Biol. 266, 814-830.
46. Oliva, B., Wastlund, M., Nilsson, O., Cardenas, R., Querol, E., Aviles, F. X. & Tapia, O. (1991). Stability and fluctuations of the potato carboxypeptidase A protein inhibitor fold: a molecular dynamics study. Biochem. Biophys. Res. Commun. 176, 616-621.
47. van Gunsteren, W. F. & Berendsen, H. J. C. (1987). Groningen Molecular Simulation (GROMOS) Library Manual, BIOMOS BV, Groningen, The Netherlands.
48. Barton, G. J. (1993). ALSCRIPT: a tool to format multiple sequence alignments. Protein Eng. 6, 37-40.
49. Evans, S. V. (1990). SETOR: hardware lighted three-dimensional solid model representations of macromolecules. J. Mol. Graph. 11, 134-138.